undamentalytics Newsletter
Sign in

Pediatrix Medical Group, Inc. income statement

In fiscal 2025, Pediatrix Medical Group, Inc. reported revenue of $1.91bn, down 4.9% on the year before, operating income of $209m (a 10.9% margin) and net income of $165m, or $1.94 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3,1833,2531,7231,7801,7341,9111,9721,9952,0131,9141,959
General and administrative373386232245249263231228238241250
Operating income572455248172982031737−69209213
Interest expense637593119110694042413633
Income before tax51438616659713581−48−101216203
Income tax18980451717271912−25153
Net income325320269−1,498−79613166−60−99165150
Diluted EPS$3.49$3.45$2.93−$17.83−$9.55$1.53$0.79−$0.73−$1.19$1.94$1.82
Diluted shares (average)93m93m92m84m83m86m84m82m83m85m82m
EBITDA66153427319812723520843−36231236

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: EHC vs MDARDT vs MDCYH vs MD

More: Hospitals stocks compared, Health Care sector, rankings of US companies

Figures from Pediatrix Medical Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pediatrix Medical Group, Inc.